|
1
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davis ME: Glioblastoma: Overview of
disease and treatment. Clin J Oncol Nurs. 20 Suppl 5:S2–S8. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrom QT, Gittleman H, Fulop J, Liu M,
Blanda R, Kromer C, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
Central brain tumor registry of the united States (CBTRUS)
statistical report: Primary brain and central nervous system tumors
diagnosed in the united states in 2008–2012. Neuro Oncol. 17 Suppl
4:iv1–iv62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells-perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Soltanian S and Matin MM: Cancer stem
cells and cancer therapy. Tumour Biol. 32:425–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
7
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Uchida N, Buck DW, He D, Reitsma MJ, Masek
M, Phan TV, Tsukamoto AS, Gage FH and Weissman IL: Direct isolation
of human central nervous system stem cells. Proc Natl Acad Sci USA.
97:14720–14725. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vescovi AL, Galli R and Reynolds BA: Brain
tumour stem cells. Nat Rev Cancer. 6:425–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Costa FF, Seftor EA, Bischof JM,
Kirschmann DA, Strizzi L, Arndt K, Bonaldo Mde F, Soares MB and
Hendrix MJ: Epigenetically reprogramming metastatic tumor cells
with an embryonic microenvironment. Epigenomics. 1:387–398. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eales KL, Hollinshead KE and Tennant DA:
Hypoxia and metabolic adaptation of cancer cells. Oncogenesis.
5:e1902016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jensen RL: Brain tumor hypoxia:
Tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a
therapeutic target. J Neurooncol. 92:317–335. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Birner P, Piribauer M, Fischer I,
Gatterbauer B, Marosi C, Ambros PF, Ambros IM, Bredel M, Oberhuber
G, Rössler K, et al: Vascular patterns in glioblastoma influence
clinical outcome and associate with variable expression of
angiogenic proteins: Evidence for distinct angiogenic subtypes.
Brain Pathol. 13:133–143. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chi JT, Wang Z, Nuyten DS, Rodriguez EH,
Schaner ME, Salim A, Wang Y, Kristensen GB, Helland A,
Børresen-Dale AL, et al: Gene expression programs in response to
hypoxia: Cell type specificity and prognostic significance in human
cancers. PLoS Med. 3:e472006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sathornsumetee S, Cao Y, Marcello JE,
Herndon JE II, McLendon RE, Desjardins A, Friedman HS, Dewhirst MW,
Vredenburgh JJ and Rich JN: Tumor angiogenic and hypoxic profiles
predict radiographic response and survival in malignant astrocytoma
patients treated with bevacizumab and irinotecan. J Clin Oncol.
26:271–278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Semenza GL: Intratumoral hypoxia,
radiation resistance, and HIF-1. Cancer Cell. 5:405–406. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vaupel P and Mayer A: Hypoxia in cancer:
Significance and impact on clinical outcome. Cancer Metastasis Rev.
26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ludwig K and Kornblum HI: Molecular
markers in glioma. J Neurooncol. 134:505–512. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gonzalez F and Huangfu D: Mechanisms
underlying the formation of induced pluripotent stem cells. Wiley
Interdiscip Rev Dev Biol. 5:39–65. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–673. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fazio C and Ricciardiello L: Inflammation
and notch signaling: A crosstalk with opposite effects on
tumorigenesis. Cell Death Dis. 7:e25152016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jundt F, Pröbsting KS, Anagnostopoulos I,
Muehlinghaus G, Chatterjee M, Mathas S, Bargou RC, Manz R, Stein H
and Dörken B: Jagged1-induced Notch signaling drives proliferation
of multiple myeloma cells. Blood. 103:3511–3515. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weijzen S, Rizzo P, Braid M, Vaishnav R,
Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC,
et al: Activation of Notch-1 signaling maintains the neoplastic
phenotype in human ras-transformed cells. Nat Med. 8:979–986. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Balint K, Xiao M, Pinnix CC, Soma A, Veres
I, Juhasz I, Brown EJ, Capobianco AJ, Herlyn M and Liu ZJ:
Activation of Notch1 signaling is required for
beta-catenin-mediated human primary melanoma progression. J Clin
Invest. 115:3166–3176. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amaya-Chanaga CI and Rassenti LZ:
Biomarkers in chronic lymphocytic leukemia: Clinical applications
and prognostic markers. Best Pract Res Clin Haematol. 29:79–89.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Evers P, Lee PP, DeMarco J, Agazaryan N,
Sayre JW, Selch M and Pajonk F: Irradiation of the potential cancer
stem cell niches in the adult brain improves progression-free
survival of patients with malignant glioma. BMC Cancer. 10:3842010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yin AH, Miraglia S, Zanjani ED,
Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J and Buck
DW: AC133, a novel marker for human hematopoietic stem and
progenitor cells. Blood. 90:5002–5012. 1997.PubMed/NCBI
|
|
33
|
Wu Y and Wu PY: CD133 as a marker for
cancer stem cells: Progresses and concerns. Stem Cells Dev.
18:1127–1134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Z: CD133: A stem cell biomarker and
beyond. Exp Hematol Oncol. 2:172013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Denko NC: Hypoxia, HIF1 and glucose
metabolism in the solid tumour. Nat Rev Cancer. 8:705–713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Muz B, de la Puente P, Azab F and Azab AK:
The role of hypoxia in cancer progression, angiogenesis,
metastasis, and resistance to therapy. Hypoxia (Auckl). 3:83–92.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gustafsson MV, Zheng X, Pereira T, Gradin
K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U and
Bondesson M: Hypoxia requires notch signaling to maintain the
undifferentiated cell state. Dev Cell. 9:617–628. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bar EE, Lin A, Mahairaki V, Matsui W and
Eberhart CG: Eberhart, hypoxia increases the expression of
stem-cell markers and promotes clonogenicity in glioblastoma
neurospheres. Am J Pathol. 177:1491–1502. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rizzino A: Concise review: The Sox2-Oct4
connection: Critical players in a much larger interdependent
network integrated at multiple levels. Stem Cells. 31:1033–1039.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Niwa H, Miyazaki J and Smith AG:
Quantitative expression of Oct-3/4 defines differentiation,
dedifferentiation or self-renewal of ES cells. Nat Genet.
24:372–376. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tai MH, Chang CC, Kiupel M, Webster JD,
Olson LK and Trosko JE: Oct4 expression in adult human stem cells:
Evidence in support of the stem cell theory of carcinogenesis.
Carcinogenesis. 26:495–502. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu J, Sato C, Cerletti M and Wagers A:
Notch signaling in the regulation of stem cell self-renewal and
differentiation. Curr Top Dev Biol. 92:367–409. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li JL and Harris AL: Notch signaling from
tumor cells: A new mechanism of angiogenesis. Cancer Cell. 8:1–3.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Politi K, Feirt N and Kitajewski J: Notch
in mammary gland development and breast cancer. Semin Cancer Biol.
14:341–347. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jiang L, Wu J, Chen Q, Hu X, Li W and Hu
G: Notch1 expression is upregulated in glioma and is associated
with tumor progression. J Clin Neurosci. 18:387–390. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang X, Chen T, Zhang J, Mao Q, Li S,
Xiong W, Qiu Y, Xie Q and Ge J: Notch1 promotes glioma cell
migration and invasion by stimulating β-catenin and NF-κB signaling
via AKT activation. Cancer Sci. 103:181–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
